4.8 Review

Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases

Journal

FRONTIERS IN IMMUNOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.00186

Keywords

5-HT; 5-HT receptor; autoimmune disease; immune cells; serotonin

Categories

Funding

  1. National Natural Science Foundation of China [81671592]
  2. Science and Technology Department of Jilin Province [20190201140JC]
  3. National Science and Technology Major Project [2017ZX10202202, 2018ZX10302206]
  4. National Key Research Plan Precision Medicine Research Key Project [2017YFC0908103]
  5. National Natural Science Foundation of Jilin Province [20160101097JC]
  6. Program for JLU Science and Technology Innovative Research Team [2017TD-08]
  7. Fundamental Research Funds for the Central Universities

Ask authors/readers for more resources

Serotonin, also known as 5-hydroxytryptamine (5-HT) is a signaling mediator that regulates emotion, behavior, and cognition. Previous studies have focused more on the roles of 5-HT in the central nervous system (CNS). However, 5-HT also shares a strong relationship with the pathological cases of tumor, inflammation, and pathogen infection. 5-HT participates in tumor cell migration, metastatic dissemination, and angiogenesis. In addition, 5-HT affects immune regulation via different 5-HT receptors (5-HTRs) expressed immune cells, including both innate and adaptive immune system. Recently, drugs targeting at 5-HT signaling were tested to be beneficial in mouse models and clinical trials of multiple sclerosis (MS) and inflammatory bowel disease (IBD). Thus, it is reasonable to assume that 5-HT participates in the pathogenesis of autoimmune diseases. However, the underlying mechanism by 5-HT modulates the development of autoimmune diseases has not been fully understood. Based on our previous studies and pertinent literature, we provide circumstantial evidence for an essential role of 5-HT, especially the regulation of 5-HT on immune cells in the pathogenesis of autoimmune diseases, which may provide a new point cut for the treatment of autoimmune diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available